131 related articles for article (PubMed ID: 8804237)
1. Hemodynamic effects of peritoneovenous shunts in hemodialysis patients with ascites.
Greenberg S; Shapiro WB; Porush JG
Am J Kidney Dis; 1996 Sep; 28(3):387-94. PubMed ID: 8804237
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic improvement after peritoneovenous shunting in nephrogenic ascites.
Morgan AG; Sivapragasam S; Fletcher P; Terry SI
South Med J; 1982 Mar; 75(3):373-4. PubMed ID: 7063919
[TBL] [Abstract][Full Text] [Related]
3. Short- and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin analysis of 14 cases.
Holm A; Rutsky EA; Aldrete JS
Am Surg; 1989 Nov; 55(11):645-52. PubMed ID: 2479308
[TBL] [Abstract][Full Text] [Related]
4. Poor outcome from peritoneovenous shunts for refractory ascites.
Scholz DG; Nagorney DM; Lindor KD
Am J Gastroenterol; 1989 May; 84(5):540-3. PubMed ID: 2719011
[TBL] [Abstract][Full Text] [Related]
5. Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.
Koyama S; Nogami A; Yoneda M; Cheng S; Koike Y; Takeuchi Y; Iwaki M; Kobayashi T; Saito S; Utsunomiya D; Nakajima A
Tomography; 2024 Mar; 10(4):471-479. PubMed ID: 38668394
[TBL] [Abstract][Full Text] [Related]
6. Successful use of the Denver peritoneovenous shunt in patients with nephrogenic ascites.
Hobar PC; Turner WW; Valentine RJ
Surgery; 1987 Feb; 101(2):161-4. PubMed ID: 3810487
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of externalized peritoneovenous shunt (EPVS) for malignant ascites.
Tokue H; Takeuchi Y; Arai Y; Sofue K; Sakamoto N; Tsushima Y; Endo K
World J Surg Oncol; 2011 Jul; 9():82. PubMed ID: 21777451
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites.
Marcus RG; Messana J; Swartz R
Am J Med; 1992 Jul; 93(1):35-40. PubMed ID: 1626571
[TBL] [Abstract][Full Text] [Related]
9. LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized, prospective trial.
Fulenwider JT; Galambos JD; Smith RB; Henderson JM; Warren WD
Arch Surg; 1986 Mar; 121(3):351-5. PubMed ID: 3947233
[TBL] [Abstract][Full Text] [Related]
10. Ascites reinfusion dialysis (ARD) for renal failure with refractory ascites.
McGill RL; Bakos JR; Marcus RJ
Clin Nephrol; 2004 Nov; 62(5):374-9. PubMed ID: 15571183
[TBL] [Abstract][Full Text] [Related]
11. Peritoneovenous shunts for palliation of malignant ascites.
Mamada Y; Yoshida H; Taniai N; Bandou K; Shimizu T; Kakinuma D; Mizuguchi Y; Ishikawa Y; Akimaru K; Tajiri T
J Nippon Med Sch; 2007 Oct; 74(5):355-8. PubMed ID: 17965529
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous peritoneovenous shunt for treatment of refractory ascites.
Won JY; Choi SY; Ko HK; Kim SH; Lee KH; Lee JT; Lee DY
J Vasc Interv Radiol; 2008 Dec; 19(12):1717-22. PubMed ID: 18948021
[TBL] [Abstract][Full Text] [Related]
13. Management of refractory chylous ascites with peritoneovenous shunts.
Huang Y; Gloviczki P; Duncan AA; Fleming MD; Driscoll DJ; Kalra M; Oderich GS; Bower TC
J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):538-546. PubMed ID: 28623993
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites.
Park JS; Won JY; Park SI; Park SJ; Lee DY
J Vasc Interv Radiol; 2001 Dec; 12(12):1445-8. PubMed ID: 11742023
[TBL] [Abstract][Full Text] [Related]
15. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
[TBL] [Abstract][Full Text] [Related]
16. Relationship between volume status and blood pressure during chronic hemodialysis.
Leypoldt JK; Cheung AK; Delmez JA; Gassman JJ; Levin NW; Lewis JA; Lewis JL; Rocco MV
Kidney Int; 2002 Jan; 61(1):266-75. PubMed ID: 11786109
[TBL] [Abstract][Full Text] [Related]
17. Can predialysis hypertension prevent intradialytic hypotension in hemodialysis patients?
Takeda A; Toda T; Fujii T; Sasaki S; Matsui N
Nephron Clin Pract; 2006; 103(4):c137-43. PubMed ID: 16636581
[TBL] [Abstract][Full Text] [Related]
18. Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation.
Mc Causland FR; Prior LM; Heher E; Waikar SS
Am J Nephrol; 2012; 36(2):168-74. PubMed ID: 22846598
[TBL] [Abstract][Full Text] [Related]
19. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
20. Peritoneo-venous shunting in patients with cirrhotic ascites and end-stage renal failure.
Gandhi VC; Leehey DJ; Stanley MM; Nemchausky BA; Daugirdas JT; Greenlee HB; Jablokow VR; Ing TS
Am J Kidney Dis; 1985 Sep; 6(3):185-7. PubMed ID: 4036962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
